Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993975311> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W1993975311 endingPage "504" @default.
- W1993975311 startingPage "498" @default.
- W1993975311 abstract "To assess oritavancin activity in vitro against clinically relevant Gram-positive pathogens causing skin and soft-tissue infections (SSTIs) in European and US hospitals.13 262 consecutive and unique isolates deemed to be responsible for SSTIs were included. Isolates originated from 36 and 27 institutions in Europe (Israel included) and the USA, respectively, between 2010 and 2013.Oritavancin (98.8% susceptible) showed modal MIC, MIC50 and MIC90 results of 0.03, 0.03 and 0.06 mg/L, respectively, for Staphylococcus aureus. CoNS from the USA (MIC50, 0.015 mg/L) demonstrated an MIC50 value of oritavancin slightly lower than those from Europe (MIC50, 0.03 mg/L). Overall, vancomycin-resistant (VanA-phenotype) Enterococcus faecalis had oritavancin MICs (MIC50/90, 0.25/0.5 mg/L) that were 16-fold higher than those obtained for vancomycin-susceptible isolates (MIC50/90, 0.015/0.03 mg/L; 99.2%-99.8% susceptible); nevertheless, oritavancin inhibited all VanA E. faecalis at ≤0.5 mg/L. Equivalent oritavancin MICs (MIC50/90, 0.004/0.008 mg/L) were noted for all VanB and vancomycin-susceptible Enterococcus faecium, while higher MICs (MIC50/90, 0.03/0.12 mg/L) were obtained for VanA strains. Oritavancin had low MICs against the overall populations of Streptococcus pyogenes (MIC50/90, 0.03/0.12 mg/L; 98.4%-98.6% susceptible), Streptococcus agalactiae (MIC50/90, 0.03/0.06 mg/L; 97.9%-98.0% susceptible) and the Streptococcus anginosus group (MIC50/90, 0.008/0.015 mg/L; 100.0% susceptible), with slightly higher MICs for Streptococcus dysgalactiae (MIC50/90, 0.06/0.25 mg/L; ≥98.3% susceptible).Oritavancin had potent activity in vitro against this contemporary collection of European and US isolates causing SSTIs. These results describe oritavancin activity against Gram-positive pathogens collected shortly prior to its regulatory approval in the USA." @default.
- W1993975311 created "2016-06-24" @default.
- W1993975311 creator A5006715126 @default.
- W1993975311 creator A5008542312 @default.
- W1993975311 creator A5026620873 @default.
- W1993975311 creator A5037843249 @default.
- W1993975311 creator A5041157580 @default.
- W1993975311 date "2014-10-31" @default.
- W1993975311 modified "2023-10-14" @default.
- W1993975311 title "Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13)" @default.
- W1993975311 cites W1893438796 @default.
- W1993975311 cites W1996945472 @default.
- W1993975311 cites W1997217691 @default.
- W1993975311 cites W2005636153 @default.
- W1993975311 cites W2027912106 @default.
- W1993975311 cites W2085409853 @default.
- W1993975311 cites W2105627036 @default.
- W1993975311 cites W2112261879 @default.
- W1993975311 cites W2112429373 @default.
- W1993975311 cites W2113886878 @default.
- W1993975311 cites W2144817424 @default.
- W1993975311 cites W2151176484 @default.
- W1993975311 cites W2157774744 @default.
- W1993975311 cites W2161621663 @default.
- W1993975311 cites W2162082121 @default.
- W1993975311 doi "https://doi.org/10.1093/jac/dku421" @default.
- W1993975311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25362568" @default.
- W1993975311 hasPublicationYear "2014" @default.
- W1993975311 type Work @default.
- W1993975311 sameAs 1993975311 @default.
- W1993975311 citedByCount "31" @default.
- W1993975311 countsByYear W19939753112015 @default.
- W1993975311 countsByYear W19939753112016 @default.
- W1993975311 countsByYear W19939753112017 @default.
- W1993975311 countsByYear W19939753112018 @default.
- W1993975311 countsByYear W19939753112019 @default.
- W1993975311 countsByYear W19939753112021 @default.
- W1993975311 countsByYear W19939753112022 @default.
- W1993975311 countsByYear W19939753112023 @default.
- W1993975311 crossrefType "journal-article" @default.
- W1993975311 hasAuthorship W1993975311A5006715126 @default.
- W1993975311 hasAuthorship W1993975311A5008542312 @default.
- W1993975311 hasAuthorship W1993975311A5026620873 @default.
- W1993975311 hasAuthorship W1993975311A5037843249 @default.
- W1993975311 hasAuthorship W1993975311A5041157580 @default.
- W1993975311 hasBestOaLocation W19939753111 @default.
- W1993975311 hasConcept C2777677444 @default.
- W1993975311 hasConcept C2778276568 @default.
- W1993975311 hasConcept C2778980435 @default.
- W1993975311 hasConcept C2779489039 @default.
- W1993975311 hasConcept C2779895986 @default.
- W1993975311 hasConcept C2780585763 @default.
- W1993975311 hasConcept C2910829522 @default.
- W1993975311 hasConcept C501593827 @default.
- W1993975311 hasConcept C523546767 @default.
- W1993975311 hasConcept C54355233 @default.
- W1993975311 hasConcept C71924100 @default.
- W1993975311 hasConcept C86803240 @default.
- W1993975311 hasConcept C89423630 @default.
- W1993975311 hasConceptScore W1993975311C2777677444 @default.
- W1993975311 hasConceptScore W1993975311C2778276568 @default.
- W1993975311 hasConceptScore W1993975311C2778980435 @default.
- W1993975311 hasConceptScore W1993975311C2779489039 @default.
- W1993975311 hasConceptScore W1993975311C2779895986 @default.
- W1993975311 hasConceptScore W1993975311C2780585763 @default.
- W1993975311 hasConceptScore W1993975311C2910829522 @default.
- W1993975311 hasConceptScore W1993975311C501593827 @default.
- W1993975311 hasConceptScore W1993975311C523546767 @default.
- W1993975311 hasConceptScore W1993975311C54355233 @default.
- W1993975311 hasConceptScore W1993975311C71924100 @default.
- W1993975311 hasConceptScore W1993975311C86803240 @default.
- W1993975311 hasConceptScore W1993975311C89423630 @default.
- W1993975311 hasIssue "2" @default.
- W1993975311 hasLocation W19939753111 @default.
- W1993975311 hasLocation W19939753112 @default.
- W1993975311 hasOpenAccess W1993975311 @default.
- W1993975311 hasPrimaryLocation W19939753111 @default.
- W1993975311 hasRelatedWork W1859276716 @default.
- W1993975311 hasRelatedWork W1928255277 @default.
- W1993975311 hasRelatedWork W2001046639 @default.
- W1993975311 hasRelatedWork W2017814274 @default.
- W1993975311 hasRelatedWork W2037456590 @default.
- W1993975311 hasRelatedWork W2044655781 @default.
- W1993975311 hasRelatedWork W2062867631 @default.
- W1993975311 hasRelatedWork W2097177512 @default.
- W1993975311 hasRelatedWork W2164576845 @default.
- W1993975311 hasRelatedWork W2756630929 @default.
- W1993975311 hasVolume "70" @default.
- W1993975311 isParatext "false" @default.
- W1993975311 isRetracted "false" @default.
- W1993975311 magId "1993975311" @default.
- W1993975311 workType "article" @default.